K？pf-Maier P. The antitumor activity of transition and main-group metal cyclopentadienyl complexes[J]. Prog Clin Biochem Med, 1989,10:151-184.
[2]
Hashida M, Nishikava M, Yanashita F, et al. Cell-specific delivery of genes with glycosylated carriers[J]. Adv Drug Deliv Rev, 2001,52:187-196.
[3]
王彦厚,王凤山,郭学平.低相对分子质量透明质酸的制备及其促血管生成作用[J].中国生化药物杂志,2007,28(2):107-109. Wang Yanhou, Wang Fengshan, Guo Xueping. Preparation of low molecular weight hyaluronic acid and its angiogenesis effects[J]. Chinese Journal of Biochemical Pharmaceutics, 2007,28(2):107-109. (in Chinese)
[4]
K？pf-Maier P, K？pf H. Titanocene dichloride: the first metallocene with cancerostatic activity[J]. Angew Chem Int Engl, 1979,18(6):477-478.
[5]
K？pf-Maier P, K？pf H. Non-platinum group metal antitumor agents: history, current status, and perspectives[J]. Chem Rev, 1987,87(5):1137-1152.
[6]
Stachtea X, Karamanos N, Klouras N. Enhanced antritumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells[J]. Anticancer Reseach, 2009,29(8):3227-3231.
[7]
Hogan N, Cotter J, Claffey J, et al. Synthesis and cytotoxicity studies of new(dimethylamino)-functionalizedand and 7-azaindole-subotituted titanocene anticancer agents(7-azaindole=1H-pyrrolo pyridine)[J]. Helvetica Chimica Acta, 2008,91(9):1787-1797.
[8]
Sugahara K N, Murai T, Nishinakamura H, et al. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells[J]. J Biol Chem, 2003,278(34):32259-32265.
